U.S. federal trademark · Serial No. 99256171
Pharmaceutical preparations for the treatment and prevention of obesity, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease, all of the foregoing excluding renal and kidney diseases; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes, excluding those for use in connection with renal and kidney diseases.
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.